EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medicines for influencing the posttranslational modifications of histones – a tutorial review

Miklós Bege, Anikó Borbás

De Remediis · 2024

DOI: 10.71116/2rks7z60 ↗

Kurz gefasst

Fachartikel in der Zeitschrift De Remediis, 2024. Verfasst von Miklós Bege und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic therapy is a relatively novel, but undoubtedly a promising area of pharmacology. Most epigenetic drugs act by affecting enzymes and play a role in post-translational modifications of histones. The molecular targets of these medicines include histone methyltransferases, histone demethylases, isocitrate dehydrogenases, histone acetyltransferases and histone deacetylases. Since histone modifications are important regulatory signals, abnormalities in this process often lead to tumorigenesis, therefore these medicines constitute an important class of antitumor therapy. In this tutorial review, we would like to briefly overview the medicines that affect histone modifications, focusing on the currently approved ones, and briefly mention other interesting examples.

Zitieren

APA

Bege, M., & Borbás, A. (2024). Medicines for influencing the posttranslational modifications of histones – a tutorial review. De Remediis. https://doi.org/10.71116/2rks7z60

Vancouver

Bege M, Borbás A. Medicines for influencing the posttranslational modifications of histones – a tutorial review. De Remediis. 2024. doi:10.71116/2rks7z60

BibTeX
@article{Bege2024,
  author = {Bege, Miklós and Borbás, Anikó},
  title = {Medicines for influencing the posttranslational modifications of histones – a tutorial review},
  journal = {De Remediis},
  year = {2024},
  doi = {10.71116/2rks7z60}
}
Kostenlos starten →